Psygen - pharmaceutical-grade psychedelic products - clinical research - Vancouver, BC, Canada   

A New Generation of Medicine

Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications

Learn More

The future of mental health and personal development is in psychedelics.

Psygen - pharmaceutical-grade psychedelic products - clinical research - Vancouver, BC, Canada   

Pharmaceutical-Grade Products

All Psygen psychedelic products are of the highest quality, manufactured in our GMP compliant manufacturing facility.

Psygen - pharmaceutical-grade psychedelic products - clinical research - Vancouver, BC, Canada   

Psychedelics for Clinical Research

Psygen's mission is to accelerate the research and development of psychedelic drugs for medicinal and therapeutic applications.

Psygen - pharmaceutical-grade psychedelic products - clinical research - Vancouver, BC, Canada   

Psygen's Social Mandate

We are committed to donating up to 10% of all profits to our charitable foundation to provide access to therapy for low income populations, fund non-profit research programs and fund environmental programs.

The Team

Psygen - danny motyka

Danny Motyka

CEO

arrow
close

Danny Motyka

Chief Executive Officer

Danny graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.

Psygen - peter van der hayden

Peter van der Heyden

CSO

arrow
close

Peter van der Heyden

Chief Scientific Officer

Dr. van der Heyden’s scientific focus is on cGMP manufacture of lysergamides, tryptamines and phenethylamines for use in clinical trials, and on biotechnological approaches to assembling precursors and psychedelic drug molecules.

Psygen - mark haden

Mark Haden

Advisor

arrow
close

Mark Haden

Clinical Research Advisor

Mark Haden is Adjunct Professor of the UBC School of Population and Public Health. He is currently involved with the British Columbia Health Officers Council drug policy committee and provides public information on drugs and drug policy.

Our Advisors

member

David Wood

CEO

arrow
member

Mike Saliken

CEO

arrow
member

Penny Sterling

CEO

arrow
member

Mark Haden

CEO

arrow
close

David Wood

CEO

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

close

Mike Saliken

CEO

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

close

Penny Sterling

CEO

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

close

Mark Haden

CEO

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

The Team

danny motyka

Danny Motyka

CEO

Danny graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.

peter hayden

Peter van der Heyden

CSO

Dr. van der Heyden’s scientific focus is on cGMP manufacture of lysergamides, tryptamines and phenethylamines for use in clinical trials, and on biotechnological approaches to assembling precursors and psychedelic drug molecules.

raimar lobenberg

Mark Haden

Research Advisor

Mark Haden is Adjunct Professor of the UBC School of Population and Public Health. He is currently involved with the British Columbia Health Officers Council drug policy committee and provides public information on drugs and drug policy.

Our Advisors

Our Advisors

member

David Wood

CEO

member

Danny Motyka

CEO

member

David Wood

CEO

arrow

Request Research Material

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Signup to our Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Please rotate your device